Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

THERMI® LAUNCHES ARVATI™, powered by Thermi®, with newest advances in True Temperature Controlled Radiofrequency Technology

New platform with patented technology optimizes delivery of temperature-controlled monopolar radiofrequency using continuous wave technology with next-generation intelligent auto-modulation algorithms to maximize consistency and control

(PRNewsfoto/Thermi)

News provided by

Thermi

Sep 04, 2018, 10:00 ET

Share this article

Share toX

Share this article

Share toX

IRVING, Texas, Sept. 4, 2018 /PRNewswire/ -- Thermi®, an Almirall S.A. company, today announced the introduction of ARVATI™, its next-generation 510K FDA-cleared, true temperature-controlled radiofrequency platform with patented technology that powers a range of Thermi's unique and comprehensive procedures that is now commercially available in the United States. ARVATI delivers rapid, precise, and consistently controlled output of radiofrequency to tissue, thus inducing positive tissue change by stimulating collagen production to enhance various skin areas, including intimate tissue. The ARVATI platform is built upon increased power as well as optimized two-way real time temperature-controlled algorithms.

Continue Reading
New platform with patented technology optimizes delivery of temperature-controlled monopolar radiofrequency using continuous wave technology with next-generation intelligent auto-modulation algorithms to maximize consistency and control
New platform with patented technology optimizes delivery of temperature-controlled monopolar radiofrequency using continuous wave technology with next-generation intelligent auto-modulation algorithms to maximize consistency and control

The new ARVATI platform includes the well-established treatment applications of ThermiTight®, ThermiRase®, ThermiSmooth® Face and ThermiVa®, used by clinicians to address common signs of aging, and/or weight loss, which may include fine lines, post-baby body, loose skin, and intimate tissue laxity.

ARVATI amplifies the science of heat with EPIC Technology™. With optimized radiofrequency delivery, ARVATI provides consistent dosage of heat while keeping clinicians in complete control throughout the treatment. The technology also features an enhanced 50-watt capacity generator, which maximizes the power to efficiently treat all body areas while helping clinicians reach desired set temperatures 63 percent faster, thereby significantly reducing total treatment times. Additionally, ARVATI includes intelligent software that offers real-time temperature monitoring with control algorithms that ensures a consistent temperature and radiofrequency dosage throughout the treatment with all the ARVATI modalities. Initial experience shows temperature stays within 1 degree of the set temperature 99.7% of the treatment time, setting a new benchmark in consistent temperature control.

"We are committed to providing clinicians with science-based advanced technology that helps achieve their desires for safe and effective non-invasive aesthetic and medical treatments that work quickly, effectively, and efficiently while producing long-lasting and natural results," said Thermi President Vlad Paul-Blanc. "As the pioneers of true temperature-controlled radiofrequency for medical and aesthetic needs, we are excited to offer ARVATI to clinicians and patients looking for proven and innovative ways to address a variety of challenges that result from photoaging and damaged skin."

In advance of launching ARVATI, the experts at Thermi worked closely with clinicians who evaluated the advancements in ARVATI's performance as it relates to the enhancements in temperature-controlled radiofrequency delivery, speed, reliability, and overall functionality. The clinicians' early, first-hand experience confirms that the ARVATI platform delivers consistently fast treatment times, with controlled delivery while maintaining consistent tissue temperature throughout each treatment. During the early evaluation, patients also found their treatments to be comfortable and fast, and registered high satisfaction overall post-procedure.

As part of the ARVATI launch, existing Thermi customers in the U.S. will be offered the opportunity to acquire the ARVATI platform at a significant discount, and ARVATI will become available in other markets around the world in the near-term.

A Few Words from Thermi Physicians About Their Initial ARVATI Experience:

"In my office, I use a variety of Thermi treatments to tighten and improve the appearance of skin all over the body including on the face and jawline, around the arms and abdomen and the vaginal area," said dermatologist Dr. Mitchel Goldman. "Safety and convenience are key considerations for my patients, and with ARVATI, they are thrilled with the results."

According to plastic surgeon, Dr. Stanley Okoro, "Thermi's new platform, ARVATI, is very versatile and allows me to treat many different conditions. It is by far the most used machine in my practice. Worth it! I love the machine!"

Dr. Leonard Miller, plastic surgeon and founder of Thermi's original temperature-controlled capability, stated, "The ARVATI platform - with advanced instrumentation and faster procedure time - makes it easier to do treatments accurately and I can now do larger areas more effectively."

"Three excellent modifications," said urogynecologist Dr. Jeffrey Dell, "1) Definitely faster rise in temperature; 2) I can see that I'm delivering more consistent and stable radiofrequency and 3) the speed has no negative impact to patient comfort."

We are pleased that there have been more than 20 customers in the U.S. who are the first in world to acquire the new ARVATI platform, including:

William Adams Jr, William P. Adams JR, MD Plastic Surgery, Dallas TX
Janet Allenby, Allenby Cosmetic Dermatology, Delray Beach FL
Constance Barone, Barone Plastic Surgery, San Antonio TX
John Bullis, A to Zen Regenerative Medicine, Bellevue WA
Elisa Burgess, Burgess Plastic Surgery, Portland OR
Michael Churukian, Beverly Hills CA
Robert Colgrove, Jr., Vinings Surgery Center, Atlanta GA
Jason Cooper, Cooper Plastic Surgery, Jupiter FL
Holly Cutler, Face Skincare, Medical, Wellness, Bingham Farms MI
Jeffrey Dell, Institute for Female Pelvic Medicine, Knoxville, TN
Barry DiBernardo, New Jersey Plastic Surgery, Montclair NJ
E. Ronald Finger, Finger and Associates, Savannah GA 
Mitchel Goldman, Cosmetic Laser Dermatology, San Diego CA
Gerald Grubbs, RevitaLift Vitality Center of Sarasota, Sarasota, FL
Aaron Mayberry, Mayberry Plastic Surgery, Albuquerque NM
Emily McLaughlin, West Magnolia Plastic Surgery, Fort Worth, TX
Leonard Miller, Boston Center for Facial Rejuvenation, Boston MA
Stanley Okoro, Georgia Plastic Surgery, Marietta GA
Cheri Ong, Ong Institute for Plastic Surgery, Scottsdale AZ
Paul Ruff, West End Plastic Surgery, Washington D.C.
Ned Snyder, Breast and Body Center of Austin, Austin TX
Kathleen Waldorf, Waldorf Center for Plastic Surgery, Portland OR
Edward Zimmerman, Las Vegas Laser & Lipo, Las Vegas NV

About Thermi

Thermi, an Almirall company, is a global leader in advanced temperature-controlled radiofrequency technology. Thermi systems offer versatile modalities and safely deliver rapid results through controlled heating using RF to impact positive tissue change and naturally stimulate collagen production. Clinicians use Thermi technology to help address common signs of aging and/or weight loss, which may include fine lines, post-baby body, cellulite, loose skin and intimate tissue laxity, and empower people to take control over their skin, body and intimate life.

To learn more about Thermi and what its technology can offer, please visit www.thermi.com.

Thermi Media Contact:    




Almirall Investors & Corporate
Communications contact:

Sharon Robustelli          




Almirall Headquarters (Spain)

VegaRun





[email protected]    




Pablo Divasson del Fraile

T: 212.453.2276           




[email protected]

C: 347.267.3946 




T: +(34) 93 291 30 87

SOURCE Thermi

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.